ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628564 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628564; 2) Community: the network communities that were significantly associated with the response to NSC 628564; 3) Molecule: the relationships between components within communities and NSC 628564; 4) MDR: the compounds that were significantly associated with the NSC 628564.

NSC Compound Enrichment Correlation
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.0115521552688255 0.44185196
NSC 710779 Null 0.0115521552688255 0.42925714
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0115521552688255 0.42305045
NSC 686573 Null 0.0115521552688257 0.22794652
NSC 93135 OXYACANTHINE 0.0115521552688257 0.22525192
NSC 278632 Null 0.0115521552688258 0.32484638
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0115521552688258 0.60342518
NSC 31717 Tetraethylenimino-1,4-benzoquinone 0.0141354818755237 -0.2046359
NSC 633551 Null 0.0141354818755239 0.11431733
NSC 65022 Null 0.0141354818755239 0.25529351
Total:89  Current:35    [First] [Prev] [Next] [Last]